These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
319 related articles for article (PubMed ID: 22451314)
1. A butyrolactone derivative 3BDO alleviates memory deficits and reduces amyloid-β deposition in an AβPP/PS1 transgenic mouse model. Wei L; Yang H; Xie Z; Yang S; Yang H; Zhao C; Wang P; Xu S; Miao J; Zhao B; Bi J J Alzheimers Dis; 2012; 30(3):531-43. PubMed ID: 22451314 [TBL] [Abstract][Full Text] [Related]
2. 4-O-methylhonokiol attenuated memory impairment through modulation of oxidative damage of enzymes involving amyloid-β generation and accumulation in a mouse model of Alzheimer's disease. Choi IS; Lee YJ; Choi DY; Lee YK; Lee YH; Kim KH; Kim YH; Jeon YH; Kim EH; Han SB; Jung JK; Yun YP; Oh KW; Hwang DY; Hong JT J Alzheimers Dis; 2011; 27(1):127-41. PubMed ID: 21799245 [TBL] [Abstract][Full Text] [Related]
3. A modified formulation of Chinese traditional medicine improves memory impairment and reduces Aβ level in the Tg-APPswe/PS1dE9 mouse model of Alzheimer's disease. Jeon S; Bose S; Hur J; Jun K; Kim YK; Cho KS; Koo BS J Ethnopharmacol; 2011 Sep; 137(1):783-9. PubMed ID: 21762767 [TBL] [Abstract][Full Text] [Related]
4. Clioquinol reduces zinc accumulation in neuritic plaques and inhibits the amyloidogenic pathway in AβPP/PS1 transgenic mouse brain. Wang T; Wang CY; Shan ZY; Teng WP; Wang ZY J Alzheimers Dis; 2012; 29(3):549-59. PubMed ID: 22269164 [TBL] [Abstract][Full Text] [Related]
5. Gintonin, a ginseng-derived lysophosphatidic acid receptor ligand, attenuates Alzheimer's disease-related neuropathies: involvement of non-amyloidogenic processing. Hwang SH; Shin EJ; Shin TJ; Lee BH; Choi SH; Kang J; Kim HJ; Kwon SH; Jang CG; Lee JH; Kim HC; Nah SY J Alzheimers Dis; 2012; 31(1):207-23. PubMed ID: 22543851 [TBL] [Abstract][Full Text] [Related]
6. Intranasal deferoxamine reverses iron-induced memory deficits and inhibits amyloidogenic APP processing in a transgenic mouse model of Alzheimer's disease. Guo C; Wang T; Zheng W; Shan ZY; Teng WP; Wang ZY Neurobiol Aging; 2013 Feb; 34(2):562-75. PubMed ID: 22717236 [TBL] [Abstract][Full Text] [Related]
7. Effect of Tong Luo Jiu Nao on Aβ-degrading enzymes in AD rat brains. Liu Y; Hua Q; Lei H; Li P J Ethnopharmacol; 2011 Sep; 137(2):1035-46. PubMed ID: 21798326 [TBL] [Abstract][Full Text] [Related]
8. Self-assembling nanofibers alter the processing of amyloid precursor protein in a transgenic mouse model of Alzheimer's disease. Yang H; Yang H; Xie Z; Wang P; Bi J Neurol Res; 2015 Jan; 37(1):84-91. PubMed ID: 25005263 [TBL] [Abstract][Full Text] [Related]
9. Soluble Aβ levels correlate with cognitive deficits in the 12-month-old APPswe/PS1dE9 mouse model of Alzheimer's disease. Zhang W; Hao J; Liu R; Zhang Z; Lei G; Su C; Miao J; Li Z Behav Brain Res; 2011 Sep; 222(2):342-50. PubMed ID: 21513747 [TBL] [Abstract][Full Text] [Related]
10. Mitochondrial amyloid-beta levels are associated with the extent of mitochondrial dysfunction in different brain regions and the degree of cognitive impairment in Alzheimer's transgenic mice. Dragicevic N; Mamcarz M; Zhu Y; Buzzeo R; Tan J; Arendash GW; Bradshaw PC J Alzheimers Dis; 2010; 20 Suppl 2():S535-50. PubMed ID: 20463404 [TBL] [Abstract][Full Text] [Related]
11. Beneficial effects of quetiapine in a transgenic mouse model of Alzheimer's disease. He J; Luo H; Yan B; Yu Y; Wang H; Wei Z; Zhang Y; Xu H; Tempier A; Li X; Li XM Neurobiol Aging; 2009 Aug; 30(8):1205-16. PubMed ID: 18079026 [TBL] [Abstract][Full Text] [Related]
12. Stromal cell-derived factor 1α decreases β-amyloid deposition in Alzheimer's disease mouse model. Wang Q; Xu Y; Chen JC; Qin YY; Liu M; Liu Y; Xie MJ; Yu ZY; Zhu Z; Wang W Brain Res; 2012 Jun; 1459():15-26. PubMed ID: 22560596 [TBL] [Abstract][Full Text] [Related]
13. Amyloid-beta causes memory impairment by disturbing the JAK2/STAT3 axis in hippocampal neurons. Chiba T; Yamada M; Sasabe J; Terashita K; Shimoda M; Matsuoka M; Aiso S Mol Psychiatry; 2009 Feb; 14(2):206-22. PubMed ID: 18813209 [TBL] [Abstract][Full Text] [Related]
14. CART modulates beta-amyloid metabolism-associated enzymes and attenuates memory deficits in APP/PS1 mice. Yin K; Jin J; Zhu X; Yu L; Wang S; Qian L; Han L; Xu Y Neurol Res; 2017 Oct; 39(10):885-894. PubMed ID: 28743230 [TBL] [Abstract][Full Text] [Related]
15. Recombinant soluble neprilysin reduces amyloid-beta accumulation and improves memory impairment in Alzheimer's disease mice. Park MH; Lee JK; Choi S; Ahn J; Jin HK; Park JS; Bae JS Brain Res; 2013 Sep; 1529():113-24. PubMed ID: 23831521 [TBL] [Abstract][Full Text] [Related]
16. Butyrolactone derivative 3-benzyl-5-((2-nitrophenoxy) methyl)-dihydrofuran-2(3H)-one protects against amyloid-β peptides-induced cytotoxicity in PC12 cells. Yang S; Wang S; Peng N; Xie Z; Wang P; Zhao C; Wei L; Yang H; Zhao B; Miao J; Bi J J Alzheimers Dis; 2012; 28(2):345-56. PubMed ID: 21988929 [TBL] [Abstract][Full Text] [Related]
17. Effect of normobaric hyperoxia on behavioral deficits and neuropathology in Alzheimer's disease mouse model. Gao B; Long Z; Zhao L; He G J Alzheimers Dis; 2011; 27(2):317-26. PubMed ID: 21799251 [TBL] [Abstract][Full Text] [Related]
18. Protocatechuic acid improves cognitive deficits and attenuates amyloid deposits, inflammatory response in aged AβPP/PS1 double transgenic mice. Song Y; Cui T; Xie N; Zhang X; Qian Z; Liu J Int Immunopharmacol; 2014 May; 20(1):276-81. PubMed ID: 24667368 [TBL] [Abstract][Full Text] [Related]
19. FK506 reduces amyloid plaque burden and induces MMP-9 in AβPP/PS1 double transgenic mice. Hong HS; Hwang JY; Son SM; Kim YH; Moon M; Inhee MJ J Alzheimers Dis; 2010; 22(1):97-105. PubMed ID: 20847451 [TBL] [Abstract][Full Text] [Related]
20. Impaired performance of female APP/PS1 mice in the Morris water maze is coupled with increased Aβ accumulation and microglial activation. Gallagher JJ; Minogue AM; Lynch MA Neurodegener Dis; 2013; 11(1):33-41. PubMed ID: 22627185 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]